Dennis Van Epps

Dr. Dennis Van Epps is an experienced Research and Development Executive with a career that spans both academia and industry. He began his career as a tenured Professor in the Departments of Medicine, Pathology, and Microbiology at the University of New Mexico Medical School. He later joined Baxter Healthcare Corporation as a Director of Immunology and became Vice President of Research for the Immunotherapy Division. He subsequently joined Nexell Therapeutics as a Corporate Officer and Vice President of R&D where the focus was the development of FDA-approved and CE-marked human stem cell collection and delivery devices. He later joined CancerVax Corporation, a startup company developing a melanoma vaccine and an anti-angiogenic therapeutic antibody as Vice President of R&D and Corporate Officer.

Prior to joining NanoSomiX, Dr. Van Epps was Vice President of Research for the Medical Device Division of Allergan focused on implantable and injectable aesthetic devices, and Vice President, New Device Technology Assessment exploring new portfolio product opportunities. He has published over 140 scientific articles in immunology, neuroimmunology, stem cell technology, and inflammation and has been an inventor on over 20 patents.

Dennis obtained his Ph.D. in Microbiology and Immunology from the University of Illinois Medical Center in Chicago.